ALS Finding a Cure logo

ALS Finding a Cure

North America, Florida, United States, Boynton Beach

Description

ALS Finding a Cure is funding research to treat and cure ALS through global research and nationwide advocacy.

Investor Profile

ALS Finding a Cure has made 3 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Series B (33%)
  • Grant (33%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Life Science
  • Artificial Intelligence (Ai)
  • Cloud Computing
  • Information Technology
  • Non Profit
  • Neuroscience
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ALS Finding a Cure frequently co-invest with?

ATEL Ventures
North America, California, United States, San Francisco
Co-Investments: 1
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Cedars Sinai
North America, California, United States, Los Angeles
Co-Investments: 1
CSC Upshot
North America, California, United States, Palo Alto
Co-Investments: 1
Techammer
North America, New York, United States, New York
Co-Investments: 1
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 1
The ALS Association
North America, District of Columbia, United States, Washington
Co-Investments: 2

Which angels does ALS Finding a Cure often collaborate with?

Shared Deals: 1

What are some of recent deals done by ALS Finding a Cure?

EverythingALS

Seattle, Washington, United States

EverythingALS is a information technology company that provides services for patients, caregivers, researchers, and drug companies.

Artificial Intelligence (AI)Cloud ComputingInformation TechnologyNon Profit
GrantAug 22, 2023
Amount Raised: $400,000
Emulate

Boston, Massachusetts, United States

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

BiotechnologyHealth CareLife ScienceMedical
Series BOct 20, 2016
Amount Raised: $17,000,000
Amylyx Pharmaceuticals

Cambridge, Massachusetts, United States

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

BiotechnologyMedicalNeurosciencePharmaceutical
SeedJul 20, 2016
Amount Raised: $2,960,000